Abstract
During feeding, a tick's mouthpart penetrates the host's skin and damages tissues and small blood vessels, triggering the extrinsic coagulation and lectin complement pathways. To elude these defense mechanisms, ticks secrete multiple anticoagulant proteins and complement system inhibitors in their saliva. Here, we characterized the inhibitory activities of the homologous tick salivary proteins tick salivary lectin pathway inhibitor, Salp14, and Salp9Pac from Ixodesscapularis in the coagulation cascade and the lectin complement pathway. All three proteins inhibited binding of mannan-binding lectin to the polysaccharide mannan, preventing the activation of the lectin complement pathway. In contrast, only Salp14 showed an appreciable effect on coagulation by prolonging the lag time of thrombin generation. We found that the anticoagulant properties of Salp14 are governed by its basic tail region, which resembles the C terminus of tissue factor pathway inhibitor alpha and blocks the assembly and/or activity of the prothrombinase complex in the same way. Moreover, the Salp14 protein tail contributes to the inhibition of the lectin complement pathway via interaction with mannan binding lectin–associated serine proteases. Furthermore, we identified BaSO4-adsorbing protein 1 isolated from the tick Ornithodoros savignyi as a distant homolog of tick salivary lectin pathway inhibitor/Salp14 proteins and showed that it inhibits the lectin complement pathway but not coagulation. The structure of BaSO4-adsorbing protein 1, solved here using NMR spectroscopy, indicated that this protein adopts a noncanonical epidermal growth factor domain–like structural fold, the first such report for tick salivary proteins. These data support a mechanism by which tick saliva proteins simultaneously inhibit both the host coagulation cascade and the lectin complement pathway.
Highlights
In the present study, proteins from the tick salivary lectin pathway inhibitor (TSLPI)– Salp14 family were functionally and structurally characterized
D70-L104 Salp14 prevents the activation of the lectin pathway of the complement system by inhibiting C4 deposition, without blocking mannan-binding lectin (MBL) binding to mannan or the amidolytic activity of MASP1
The data presented here provide a possible explanation for the tissue factor pathway inhibitor alpha (TFPIα) C terminus activity in the lectin pathway without interfering with the MBL-associated serine protease (MASP)-2 proteolytic activity, similar to D70-L104 Salp14
Summary
In the present study, proteins from the TSLPI– Salp14 family were functionally and structurally characterized. Salp14 inhibits both the extrinsic pathway and the lectin complement pathway at early stages (Fig. 6), whereas other proteins of the TSLPI–Salp14 family would only block the latter. BSAP1 shares no sequence homology and disulfide connectivity with EGF-like domain significant reduction in the anticoagulant activity of tick salivary extracts [11].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.